Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
Sign Up to like & getrecommendations! Published in 2021 at "AJP Reports"
DOI: 10.1055/s-0041-1731057
Abstract: The atypical hemolytic uremic syndrome (aHUS) in the newborn is a rare disease, with high morbidity. Eculizumab, considered a first-line drug in older children, is not approved in neonates and in children weighing less than… read more here.
Keywords: neonatal atypical; atypical hemolytic; uremic syndrome; hemolytic uremic ... See more keywords